Found: 46
Select item for more details and to access through your institution.
Type I-conventional dendritic cells support the progression of multiple myeloma in the bone marrow.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1444821
- By:
- Publication type:
- Article
Molecular pathogenesis of multiple myeloma and its premalignant precursor.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 10, p. 3456, doi. 10.1172/JCI61188
- By:
- Publication type:
- Article
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26598-w
- By:
- Publication type:
- Article
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 2, p. 219, doi. 10.1111/bjh.13296
- By:
- Publication type:
- Article
Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 563, doi. 10.1111/bjh.13004
- By:
- Publication type:
- Article
Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.13004
- By:
- Publication type:
- Article
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
- Published in:
- Scientific Reports, 2015, p. 8428, doi. 10.1038/ncomms9428
- By:
- Publication type:
- Article
The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 316, doi. 10.1038/onc.2012.594
- By:
- Publication type:
- Article
Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0027996
- By:
- Publication type:
- Article
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Chromosome translocations in multiple myeloma.
- Published in:
- Oncogene, 2001, v. 20, n. 40, p. 5611, doi. 10.1038/sj.onc.1204641
- By:
- Publication type:
- Article
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07305-8
- By:
- Publication type:
- Article
Signaling Pathways in Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S12
- By:
- Publication type:
- Article
Individualizing Therapy Using Molecular Markers in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S170
- By:
- Publication type:
- Article
Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.
- Published in:
- EMBO Journal, 2015, v. 34, n. 9, p. 1214, doi. 10.15252/embj.201489920
- By:
- Publication type:
- Article
Initial genome sequencing and analysis of multiple myeloma.
- Published in:
- Nature, 2011, v. 471, n. 7339, p. 467, doi. 10.1038/nature09837
- By:
- Publication type:
- Article
MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.
- Published in:
- Nature, 2011, v. 470, n. 7332, p. 124, doi. 10.1038/nature09658
- By:
- Publication type:
- Article
Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
- Published in:
- Immunological Reviews, 2003, v. 194, n. 1, p. 96, doi. 10.1034/j.1600-065X.2003.00052.x
- By:
- Publication type:
- Article
Immunosurveillance and therapy of multiple myeloma are CD226 dependent.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Immunosurveillance and therapy of multiple myeloma areCD226 dependent.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 2077, doi. 10.1172/JCI77181
- By:
- Publication type:
- Article
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling.
- Published in:
- Nature Immunology, 2008, v. 9, n. 12, p. 1364, doi. 10.1038/ni.1678
- By:
- Publication type:
- Article
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
- Published in:
- Nature Communications, 2015, v. 6, n. 10, p. 8428, doi. 10.1038/ncomms9428
- By:
- Publication type:
- Article
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 494, p. 1, doi. 10.1126/scitranslmed.aau9087
- By:
- Publication type:
- Article
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
- By:
- Publication type:
- Article
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
- By:
- Publication type:
- Article
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
- By:
- Publication type:
- Article
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
- By:
- Publication type:
- Article
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0210-z
- By:
- Publication type:
- Article
V. Molecular classification and risk stratification of myeloma.
- Published in:
- Hematological Oncology, 2013, v. 31, p. 38, doi. 10.1002/hon.2065
- By:
- Publication type:
- Article
Osteopontin dysregulation and lytic bone lesions in multiple myeloma.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 1, p. 16, doi. 10.1002/hon.803
- By:
- Publication type:
- Article
Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. E504, doi. 10.1002/ajh.24548
- By:
- Publication type:
- Article
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 3, p. 237, doi. 10.1002/ajh.23620
- By:
- Publication type:
- Article
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
- By:
- Publication type:
- Article
Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00164-5
- By:
- Publication type:
- Article
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y
- By:
- Publication type:
- Article
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 3, p. 326, doi. 10.1111/j.1365-2141.2011.08949.x
- By:
- Publication type:
- Article
Role of Pirh2 in Mediating the Regulation of p53 and c-Myc.
- Published in:
- PLoS Genetics, 2011, v. 7, n. 11, p. 1, doi. 10.1371/journal.pgen.1002360
- By:
- Publication type:
- Article
MULTIPLE MYELOMA: EVOLVING GENETIC EVENTS AND HOST INTERACTIONS.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 3, p. 175, doi. 10.1038/nrc746
- By:
- Publication type:
- Article